These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30771230)

  • 1. The skewed frequency of B-cell subpopulation CD19
    Wang H; Liu C; Chen W; Ding G
    J Cell Biochem; 2019 Jul; 120(7):11490-11497. PubMed ID: 30771230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
    Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
    Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral CD24hi CD27+ CD19+ B cells subset as a potential biomarker in naïve systemic lupus erythematosus.
    Jin L; Weiqian C; Lihuan Y
    Int J Rheum Dis; 2013 Dec; 16(6):698-708. PubMed ID: 24286662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective CD19+CD24
    Cencioni MT; Ali R; Nicholas R; Muraro PA
    Mult Scler; 2021 Jul; 27(8):1187-1197. PubMed ID: 32924828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated circulating CD19
    Deng B; Deng L; Liu M; Zhao Z; Huang H; Tu X; Liang E; Tian R; Wang X; Wang R; Lin H; Yu Y; Peng A; Xu P; Bao K; He M
    Immunol Lett; 2023 Sep; 261():58-65. PubMed ID: 37553031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.
    Blair PA; Noreña LY; Flores-Borja F; Rawlings DJ; Isenberg DA; Ehrenstein MR; Mauri C
    Immunity; 2010 Jan; 32(1):129-40. PubMed ID: 20079667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19
    Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
    Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of CD19
    Gu Y; Li K; Sun J; Zhang J
    J Eur Acad Dermatol Venereol; 2020 Dec; 34(12):2863-2870. PubMed ID: 32242984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
    Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
    Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.
    Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q
    Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD19
    Yang M; Du C; Wang Y; Liu J
    Exp Ther Med; 2017 Oct; 14(4):3887-3893. PubMed ID: 29042997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An age-related numerical and functional deficit in CD19(+) CD24(hi) CD38(hi) B cells is associated with an increase in systemic autoimmunity.
    Duggal NA; Upton J; Phillips AC; Sapey E; Lord JM
    Aging Cell; 2013 Oct; 12(5):873-81. PubMed ID: 23755918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis.
    Kim Y; Kim G; Shin HJ; Hyun JW; Kim SH; Lee E; Kim HJ
    J Neuroinflammation; 2018 Oct; 15(1):300. PubMed ID: 30373595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
    Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
    Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
    Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
    Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory B cells (CD19(+)CD38(hi)CD24(hi)) in alloimmunized and non-alloimmunized children with β-thalassemia major.
    Zahran AM; Elsayh KI; Saad K; Embaby M; Ali AM
    Blood Cells Mol Dis; 2016 Mar; 57():91-6. PubMed ID: 26852663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD19
    Xiong H; Tang Z; Xu Y; Shi Z; Guo Z; Liu X; Tan G; Ai X; Guo Q
    Adv Rheumatol; 2022 Dec; 62(1):48. PubMed ID: 36494762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
    Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
    Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus.
    Menon M; Blair PA; Isenberg DA; Mauri C
    Immunity; 2016 Mar; 44(3):683-697. PubMed ID: 26968426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased number of CD19
    Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
    Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.